illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10
Mycoplasma Pneumoniae Dna Assay System. 510(k) K160829, from Meridian Bioscience, Inc. (Cincinnati, OH). Product code OZX, class 2.
As of Nov 20, 2026, K160829 is an FDA 510(k) held by Meridian Bioscience, Inc., substantially equivalent on Jun 13, 2016 after 80 days, with no recalls tied to it in FDA's recall database.
- Review time: 80 days
- Recalls: 0
The illumigene Mycoplasma Direct DNA amplification assay, performed on the illumipro-10 â„¢, is a qualitative in vitro diagnostic test for the direct detection of DNA from Mycoplasma pneumoniae in human throat swabs obtained from patients suspected of having Mycoplasma pneumoniae infection.
- Illumigene Mycoplasama Dna Amplification Assay, and Illumigene Mycoplasma External Controls KitK123423 · Meridian Bioscience, Inc. · Jun 5, 2013
- illumigene Mycoplasma DNA Amplification AssayK152800 · Meridian Bioscience, Inc. · Oct 23, 2015
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 25, 2016
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files